11.23
price down icon2.43%   -0.28
 
loading
前日終値:
$11.51
開ける:
$11.49
24時間の取引高:
848.53K
Relative Volume:
1.36
時価総額:
$912.48M
収益:
$133.62M
当期純損益:
$-177.37M
株価収益率:
-3.8858
EPS:
-2.89
ネットキャッシュフロー:
$23.50M
1週間 パフォーマンス:
-14.92%
1か月 パフォーマンス:
-25.03%
6か月 パフォーマンス:
-44.54%
1年 パフォーマンス:
-49.25%
1日の値動き範囲:
Value
$10.99
$11.49
1週間の範囲:
Value
$10.89
$13.53
52週間の値動き範囲:
Value
$10.89
$27.24

Xencor Inc Stock (XNCR) Company Profile

Name
名前
Xencor Inc
Name
セクター
Healthcare (1166)
Name
電話
626-305-5900
Name
住所
465 N. HALSTEAD ST., PASADENA, CA
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
XNCR's Discussions on Twitter

XNCR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
XNCR
Xencor Inc
11.23 912.48M 133.62M -177.37M 23.50M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Xencor Inc Stock (XNCR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-12 開始されました Wells Fargo Overweight
2024-12-02 アップグレード Piper Sandler Neutral → Overweight
2024-04-16 繰り返されました BTIG Research Buy
2024-02-28 ダウングレード Piper Sandler Overweight → Neutral
2023-05-19 開始されました BofA Securities Buy
2022-12-06 開始されました Cowen Outperform
2022-10-13 アップグレード Raymond James Outperform → Strong Buy
2022-09-21 開始されました JP Morgan Overweight
2022-07-06 再開されました Canaccord Genuity Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-01-21 開始されました SMBC Nikko Outperform
2021-12-15 開始されました H.C. Wainwright Buy
2021-10-15 再開されました BTIG Research Buy
2021-02-24 アップグレード Raymond James Mkt Perform → Outperform
2020-03-04 開始されました Barclays Underweight
2020-02-25 アップグレード Guggenheim Neutral → Buy
2020-01-30 開始されました RBC Capital Mkts Outperform
2019-11-20 再開されました Guggenheim Neutral
2019-08-07 ダウングレード Guggenheim Buy → Neutral
2019-08-07 ダウングレード Raymond James Outperform → Mkt Perform
2019-06-13 開始されました Mizuho Buy
2019-04-12 開始されました Guggenheim Buy
2019-03-27 開始されました Berenberg Buy
2019-03-15 開始されました Raymond James Outperform
2018-09-10 再開されました BTIG Research Buy
2018-03-28 再開されました Leerink Partners Outperform
2017-03-02 開始されました Instinet Neutral
2017-03-02 繰り返されました Wedbush Outperform
2016-10-04 開始されました Piper Jaffray Overweight
2015-12-22 開始されました Canaccord Genuity Buy
2015-08-05 繰り返されました MLV & Co Buy
2015-02-12 繰り返されました Oppenheimer Outperform
2015-01-28 繰り返されました MLV & Co Buy
2014-07-11 開始されました Oppenheimer Outperform
すべてを表示

Xencor Inc (XNCR) 最新ニュース

pulisher
Mar 27, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Bought by Swiss National Bank - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

PNC Financial Services Group Inc. Raises Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Xencor stock touches 52-week low at $12.53 amid market challenges - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

When (XNCR) Moves Investors should Listen - Stock Traders Daily

Mar 24, 2025
pulisher
Mar 21, 2025

Charles Schwab Investment Management Inc. Boosts Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Armenian Reporter

Mar 21, 2025
pulisher
Mar 21, 2025

Charles Schwab Investment Management Inc. Purchases 3,652 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Amundi Acquires 24,494 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

US Bancorp DE Reduces Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 19, 2025
pulisher
Mar 14, 2025

Bank of New York Mellon Corp Purchases 18,586 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Federal Circuit Rules Jepson Claims Need Full Written Description: Another Nail in the Coffin - Patently-O

Mar 14, 2025
pulisher
Mar 14, 2025

Xencor (NASDAQ:XNCR) Stock Rating Lowered by StockNews.com - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Fed. Circ. Dings Antibody Patent App For Lacking Description - Law360

Mar 13, 2025
pulisher
Mar 13, 2025

Xencor Appoints Todd Simpson To Board Of Directors -March 13, 2025 at 05:31 pm EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Xencor Appoints Todd Simpson to Board of Directors - Sharewise

Mar 13, 2025
pulisher
Mar 13, 2025

Xencor Strengthens Board with Veteran Biotech CFO Behind Seagen's Multi-Billion Success - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Xencor CEO Dahiyat sells $268,080 in common stock - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Xencor’s EVP Nancy Valente sells $34,876 in stock By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

Antibody Humanization Market Critical Analysis with Expert Opinion: Genentech, Adimab, Xencor - openPR

Mar 12, 2025
pulisher
Mar 12, 2025

Xencor Sr. vice president sells $131,851 in shares By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Xencor’s SVP sells $78,047 in stock By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 11, 2025

Xencor stock touches 52-week low at $13.2 amid market challenges - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

Xencor’s SVP sells $78,047 in stock - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Xencor’s EVP Nancy Valente sells $34,876 in stock - Investing.com India

Mar 11, 2025
pulisher
Mar 11, 2025

Xencor CEO Dahiyat sells $268,080 in common stock By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Xencor Executives Sell Shares to Cover Taxes - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Xencor stock touches 52-week low at $13.2 amid market challenges By Investing.com - Investing.com South Africa

Mar 11, 2025
pulisher
Mar 11, 2025

Mutual of America Capital Management LLC Buys Shares of 10,600 Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Xencor, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Top Premarket Gainers -March 07, 2025 at 07:34 am EST - Marketscreener.com

Mar 07, 2025
pulisher
Mar 06, 2025

Xencor (NASDAQ:XNCR) Upgraded by StockNews.com to “Hold” Rating - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

How does Xencor Inc (XNCR) change from a tortoise to a hare? - SETE News

Mar 05, 2025
pulisher
Mar 05, 2025

Xencor, Inc. (NASDAQ:XNCR) Stake Increased by Amalgamated Bank - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Xencor stock touches 52-week low at $14.16 amid market challenges - Investing.com

Mar 05, 2025
pulisher
Mar 04, 2025

Examining the Potential Price Growth of Xencor Inc (XNCR) - Knox Daily

Mar 04, 2025
pulisher
Mar 04, 2025

Xencor stock touches 52-week low at $14.16 amid market challenges By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 03, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives $34.88 Consensus Target Price from Analysts - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

(XNCR) Technical Data - Stock Traders Daily

Mar 03, 2025
pulisher
Mar 02, 2025

Principal Financial Group Inc. Grows Stock Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

Wells Fargo & Company Issues Pessimistic Forecast for Xencor (NASDAQ:XNCR) Stock Price - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Xencor, Inc. (NASDAQ:XNCR) Stake Raised by Rhumbline Advisers - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Sanctuary Advisors LLC Raises Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Xencor (NASDAQ:XNCR) Posts Quarterly Earnings Results - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Promising Pipeline and Innovative Platforms Drive Buy Rating for Xencor - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Xencor’s Strategic Advancements and Financial Strength Signal Positive Outlook - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Xencor (NASDAQ:XNCR) Trading 7.8% Higher on Better-Than-Expected Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

RBC Capital Adjusts Xencor Price Target to $32 From $34, Maintains OutperformSpeculative Risk Rating - Marketscreener.com

Feb 28, 2025

Xencor Inc (XNCR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Xencor Inc (XNCR) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Eckert Celia
SVP, GENERAL COUNSEL
Mar 10 '25
Sale
13.60
5,740
78,047
63,507
Desjarlais John R
SR. VICE PRESIDENT & CSO
Mar 10 '25
Sale
13.60
9,697
131,851
236,574
Dahiyat Bassil I
PRESIDENT & CEO
Mar 10 '25
Sale
13.60
19,716
268,080
465,419
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):